Bioray Biotech Co

Bioray Biotech Co EBITDA per Employee

EBITDA per Employee of Bioray Biotech Co (7561.TWO) as of Oct 15, 2026.

EBITDA per Employee

-TWD

Last updated:

EBITDA per Employee of Bioray Biotech Co is 2026 - TWD. EBITDA per Employee of Bioray Biotech Co was 2025 - TWD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bioray Biotech Co Stock analysis

What does Bioray Biotech Co do? Bioray Biotech Co Ltd is a company based in Tainan, Taiwan, operating within the Health Care sector, specifically in the Biotechnology industry. The company went public on July 6, 2020, with its ticker listed as 7561.TWO and ISIN TW0007561B13. Bioray Biotech focuses on the development of biological health products, functional medical testing, and cell storage and preparation services. The company's product portfolio includes personalized probiotics, anti-allergic and intestinal probiotics, diabetes probiotics, and female urinary tract health products. In the functional medical testing segment, the company offers services such as personalized bacteria testing, personalized fungi testing, intestinal normal bacteria analysis, quantitative detection of magnesium in red blood cells, polymorphism analysis of metabolic-related genes, and lymphocyte grouping. For cell storage and preparation, Bioray Biotech provides stem cell storage, immune cell storage, and cytokine-induced killer (CIK) immune cell preparations. The company's website is https://bio-ray.com.tw/, where further information about its services and products can be found. Bioray Biotech is engaged in the development and provision of specialized health-related services and products, primarily targeting personalized health solutions through biotechnology. Bioray Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioray Biotech Co stock

On Eulerpool you can find the complete historical development of EBITDA per Employee Bioray Biotech Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Bioray Biotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Bioray Biotech Co

All Key Metrics — Bioray Biotech Co